Where Do We Go from Here? – An Analysis of Teva’s Impact on IPR Practice and How the Federal Circuit Is Attempting to Limit the Impact of Teva
Where Do We Go from Here? - An Analysis of [...]
Where Do We Go from Here? - An Analysis of [...]
35 USC § 289-‐ An Important Feature of U.S. Design [...]
On the Commonality Between Literature and Patents
Trademark Infringement of Original Equipment Manufacture (OEM) For Export in [...]
What is a Software Patent?
Is There a Need for Patent Reform Legislation?
Trademark Oppositions in the United States
Should A Good Faith Belief In Patent Invalidity Negate Induced [...]
Hands-On Counsel
Avoiding the Litigation Rabbit Hole: Federal Circuit Endorses Pre-Answer § [...]